BioMed Research International / 2013 / Article / Fig 3

Research Article

High Expression of H3K27me3 Is an Independent Predictor of Worse Outcome in Patients with Urothelial Carcinoma of Bladder Treated with Radical Cystectomy

Figure 3

Kaplan-Meier survival analysis of H3K27me3 expression in patients with UCB (log-rank test). Total, probability of survival of all patients with UCB: low expression (dashed line), ; high expression (solid line), . G1, probability of survival of G1 patients with UCB: low expression (dashed line), ; high expression (solid line), . G2, probability of survival of G2 patients with UCB: low expression (dashed line), ; high expression (solid line), . G3, probability of survival of G3 patients with UCB: low expression (dashed line), ; high expression (solid line), . pT1, probability of survival of pT1 patients with UCB: low expression (dashed line), ; high expression (solid line), . pT2, probability of survival of pT2 patients with UCB: low expression (dashed line), ; high expression (solid line), . pT3, probability of survival of pT3 patients with UCB: low expression (dashed line), ; high expression (solid line), . pT4, probability of survival of pT4 patients with UCB: low expression (dashed line), ; high expression (solid line), . pN, probability of survival of pN− patients with UCB: low expression (dashed line), ; high expression (solid line), . pN+, probability of survival of pN+ patients with UCB: low expression (dashed line), ; high expression (solid line), .
390482.fig.003a
(a)
390482.fig.003b
(b)
390482.fig.003c
(c)
390482.fig.003d
(d)
390482.fig.003e
(e)
390482.fig.003f
(f)
390482.fig.003g
(g)
390482.fig.003h
(h)
390482.fig.003i
(i)
390482.fig.003j
(j)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.